EUVIMEDEUVIMED entdecken
Crossref

TP53 mutation may underlie increasing incidence of external auditory canal carcinoma

A Pandya iD, D Chandrasekharan iD, K Suchak iD, J S Virk iD

The Journal of Laryngology & Otology · 2025

DOI: 10.1017/s0022215124002159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Laryngology & Otology, 2025. Verfasst von A Pandya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology and Pathology Department, Royal London Hospital, Barts NHS Health Trust, London, UK. Hauptthemen laut MEDLINE: Ear Neoplasms, Ear Canal, Tumor Suppressor Protein p53, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary neoplasm of the external auditory canal has historically been documented to have a low incidence rate of between one and six per million internationally, with UK incidence yet to be officially cited.

Methods

Here, we report a rise in incidence at a single UK trust with seven carcinomas (six T4 external auditory canal squamous cell and one T4 basal cell) reported within an 18-month period. All tumours underwent next generation sequencing.

Results

The cases recorded represented a twofold rise in incidence in reference to international literature from a population-adjusted estimate of 0.5–3 cases for the catchment area to seven cases. All cases were treated with temporal bone resections (n = 7) and with post-operative radiotherapy in six cases. Tumour analysis showed all were TP53 mutant and human papilloma virus (HPV)/ P16 negative.

Conclusion

We suggest chronic inflammation and genetic alterations as putative contributory factors in our case series and outline clinical strategies for timely detection of external auditory canal neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ear NeoplasmsEar CanalTumor Suppressor Protein p53Carcinoma, Squamous CellBasal Cell CarcinomaHumansIncidenceMaleMutationFemaleMiddle AgedUnited KingdomAgedAdultAged, 80 and over

Stichwörter der Autor:innen

Epigeneticsexternal auditory canalneoplasmssquamous cell carcinomatp53 mutations

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Otolaryngology and Pathology Department, Royal London Hospital, Barts NHS Health Trust, London, UK.

ORCID-Profile: A Pandya, D Chandrasekharan, K Suchak, J S Virk

Zitieren

APA

Pandya, A., Chandrasekharan, D., Suchak, K., & Virk, J. S. (2025). TP53 mutation may underlie increasing incidence of external auditory canal carcinoma. The Journal of Laryngology & Otology. https://doi.org/10.1017/s0022215124002159

Vancouver

Pandya A, Chandrasekharan D, Suchak K, Virk JS. TP53 mutation may underlie increasing incidence of external auditory canal carcinoma. The Journal of Laryngology & Otology. 2025. doi:10.1017/s0022215124002159

BibTeX
@article{Pandya2025,
  author = {Pandya, A and Chandrasekharan, D and Suchak, K and Virk, J S},
  title = {TP53 mutation may underlie increasing incidence of external auditory canal carcinoma},
  journal = {The Journal of Laryngology & Otology},
  year = {2025},
  doi = {10.1017/s0022215124002159}
}
Kostenlos starten →